NCT02146534View on ClinicalTrials.gov

Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Multiple Sclerosis
Interventions
DRUG

extended release fampridine

pts will receive Fampyra 10 mg BID PO for the duration of the study

DRUG

Placebo

placebo will be taken PO BID

Trial Locations (1)

J9J 0A5

Clinique Neuro-Outaouais, Gatineau

All Listed Sponsors
collaborator

CogState Ltd.

INDUSTRY

lead

Clinique Neuro-Outaouais

OTHER

NCT02146534 - Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients | Biotech Hunter | Biotech Hunter